BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19054856)

  • 1. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
    Haldane J
    BJOG; 2008 Nov; 115(12):1587-8; author reply 1588-9. PubMed ID: 19054856
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
    Gomperts R; Kleiverda G; Gemzell K; Davies S; Jelinska K
    BJOG; 2008 Nov; 115(12):1578-9. PubMed ID: 19035995
    [No Abstract]   [Full Text] [Related]  

  • 3. Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
    Gomperts RJ; Jelinska K; Davies S; Gemzell-Danielsson K; Kleiverda G
    BJOG; 2008 Aug; 115(9):1171-5; discussion 1175-8. PubMed ID: 18637010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Availability of medical abortion pills and the role of chemists: a study from Bihar and Jharkhand, India.
    Ganatra B; Manning V; Pallipamulla SP
    Reprod Health Matters; 2005 Nov; 13(26):65-74. PubMed ID: 16291487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Availability and acceptability of medical abortion in Nepal: health care providers' perspectives.
    Tamang A; Tamang J
    Reprod Health Matters; 2005 Nov; 13(26):110-9. PubMed ID: 16291492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Online access to abortion medications: a review of utilization and clinical outcomes.
    Endler M; Cleeve A; Gemzell-Danielsson K
    Best Pract Res Clin Obstet Gynaecol; 2020 Feb; 63():74-86. PubMed ID: 31383555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In brief: Mifepristone by mail for pregnancy termination.
    Med Lett Drugs Ther; 2022 Jan; 64(1642):11. PubMed ID: 35134042
    [No Abstract]   [Full Text] [Related]  

  • 8.
    Fuleihan C
    Am J Law Med; 2020 Nov; 46(4):507-517. PubMed ID: 33413017
    [No Abstract]   [Full Text] [Related]  

  • 9. Improving access to safe abortion in a rural primary care setting in India: experience of a service delivery intervention.
    Iyengar K; Iyengar SD
    Reprod Health; 2016 May; 13(1):54. PubMed ID: 27165519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria.
    Okonofua F; Shittu O; Shochet T; Diop A; Winikoff B
    Int J Gynaecol Obstet; 2014 Apr; 125(1):49-52. PubMed ID: 24507887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, efficacy and acceptability of outpatient mifepristone-misoprostol medical abortion through 70 days since last menstrual period in public sector facilities in Mexico City.
    Sanhueza Smith P; Peña M; Dzuba IG; García Martinez ML; Aranguré Peraza AG; Bousiéguez M; Shochet T; Winikoff B
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):75-82. PubMed ID: 25702071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing medical abortion with mifepristone and misoprostol in Norway 1998-2013.
    Løkeland M; Bjørge T; Iversen OE; Akerkar R; Bjørge L
    Int J Epidemiol; 2017 Apr; 46(2):643-651. PubMed ID: 28031316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FDA considering restricted access to "abortion pill".
    Sibbald B
    CMAJ; 2000 Sep; 163(5):586. PubMed ID: 11006770
    [No Abstract]   [Full Text] [Related]  

  • 14. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
    Chai J; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Medical abortion provided by telemedicine to women in Latin America: complications and their treatment].
    Larrea S; Palència L; Perez G
    Gac Sanit; 2015; 29(3):198-204. PubMed ID: 25770915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Termination of pregnancy at 9-13 weeks' amenorrhoea with mifepristone and misoprostol.
    Ashok PW; Flett GM; Templeton A
    Lancet; 1998 Aug; 352(9127):542-3. PubMed ID: 9716062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
    Lyus R
    BJOG; 2011 Aug; 118(9):1148-9. PubMed ID: 21749622
    [No Abstract]   [Full Text] [Related]  

  • 20. Mifepristone- and misoprostol-induced mid-trimester termination of pregnancy: a review of 272 cases.
    Rose SB; Shand C; Simmons A
    Aust N Z J Obstet Gynaecol; 2006 Dec; 46(6):479-85. PubMed ID: 17116051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.